As the pandemic still rages in many countries and bruised countries like the UK take their first steps to kick start the economy will we return to our normal reliance on the global supply chains? We business and the public look to buy products made closer to home, Buy British? Will the business be able to sustain the higher costs? The fragility of the global supply chain became very apparent as first China then India closed down and the pharma supply chain to most of the world was under threat. Britain has a pandemic and Brexit to deal with in the coming months and many of the companies who wish to supply the UK will be watching closely to see what the MHRA will announce in the coming months. The NHS keeps the costs of medicines in the UK down and therefore this is another consideration for suppliers is there enough margin, is it worth the effort should they focus on bigger markets. Over the past few months, the key UK suppliers have collaborated to ensure the efficient use of resources and to protect the fragile supply chain to maintain the supply of key medicines, sharing intelligence to ensure active substances and excipients were used wisely to prevent out of stock situations. It is unlikely that the UK will run a buy British for pharmaceuticals as the NHS probably cannot afford to.
Buy British, will the public shun Chinese products?
by Jackie (née Heneghan) Peck | Jun 25, 2020 | Blog
Recent Posts
Testimonials
“Very well constructed, was done at a good pace and the trainer was very informative and made sure we all understood what was being said before moving on” – GDP Training October 2021
GDP Training - October 2021
“My experience working with Steven has been calm and reassuring. I have struggled to find specific requirements for API distribution from my previous consultant and the Green Guide. I start working with Steven shortly after taking an API training course at PCL, the consultation is beyond my expectation, he helps me identify my specific set of issues quickly and advise me how I should address them to achieve compliance. In the short time I am working with Steven gives me clarity that I hav… Read more
Consultancy Services
“Brilliant training provided, answered all questions.” Ashish Morar – Course Rating 10/10
GDP & RP Training
I attended one of the first virtual GDP Responsible Person Cogent “Gold Standard” training sessions due to the Covid-19 social distancing requirements. regardless of the circumstances the training was well organised and delivered to the required standard. This is why I recommended my associates to utilise PCL. Thank you Ryan, Sally, Adel and Jackie. Goncalo Sousa – Quality Head UK at the Janssen Pharmaceutical Companies of Johnson & Johnson 05/05/2020
Cogent Gold Standard GDP Online Training
“Excellent – Helpful. I was in a small group setting, so very informal and easy to ask questions.” Justin – Course Rating 9/10
GDP & RP Training
“Course was very informative and taught/explained very well.” Craig – Course Rating 9/10
GDP Training
Waisain Al-Shamary was a lovely tutor – she allowed people to contribute and she managed a couple of strong characters with grace and patience – December 2020
Cogent Gold Standard Responsible Person Training
“An ‘All-Inclusive’ Training” Pop Ohelga – Course Rating 10/10
GDP & RP Training
“Very informative and lots of opportunity to ask questions and speak with other people on the course.” Megan – Course Rating 10/10
GDP & RP Training
“For someone with a bare minimal knowledge of WDA this course helped understand the legal, general and business complexities quite well.” Cogent Online Training – March 2021
Cogent - March 2021